Skip to main content

Nirmish Ramesh Shah, MD

Associate Professor of Medicine
Associate Professor in Pediatrics
Associate Professor in the School of Nursing
Campus mail: Department of Medicine, Duke S, Durham, NC 27710
Phone: (919) 668-5178
Email address: nirmish.shah@duke.edu

Education and Training

  • Fellowship, Pediatric Hematology/ Oncology, Duke University School of Medicine, 2007 - 2010
  • Fellowship, Adult Hematology/Oncology, East Carolina University, 2004 - 2005
  • Resident, Medicine Pediatrics, East Carolina University, 2000 - 2004
  • M.D., American University of the Caribbean, 2000

Selected Grants and Awards

Publications

Hankins, J. S., and N. Shah. “Tackling adherence in sickle cell disease with mHealth.” The Lancet Haematology 7, no. 10 (October 1, 2020): e713–14. https://doi.org/10.1016/S2352-3026(20)30299-4.

Full Text

Thom, Howard, Jeroen Jansen, Jason Shafrin, Lauren Zhao, George Joseph, Hung-Yuan Cheng, Subhajit Gupta, and Nirmish Shah. “Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis.” Bmj Open 10, no. 9 (September 17, 2020): e034147. https://doi.org/10.1136/bmjopen-2019-034147.

Full Text

Shah, Nirmish R., Menaka Bhor, Dominick Latremouille-Viau, Vikash Kumar Sharma, Gary A. Puckrein, Patrick Gagnon-Sanschagrin, Ankur Khare, et al. “Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance - the perspective of private and public payers.” J Med Econ, September 9, 2020, 1–11. https://doi.org/10.1080/13696998.2020.1813144.

Full Text

Oyedeji, Charity I., Regina D. Crawford, and Nirmish Shah. “Adherence to Iron Chelation Therapy with Deferasirox Formulations among Patients with Sickle Cell Disease and β-thalassemia.” J Natl Med Assoc, September 3, 2020. https://doi.org/10.1016/j.jnma.2020.08.007.

Full Text

Vaughn, Jacqueline, Nirmish Shah, Jude Jonassaint, Nichol Harris, Sharron Docherty, and Ryan Shaw. “User-Centered App Design for Acutely Ill Children and Adolescents.” J Pediatr Oncol Nurs, July 10, 2020, 1043454220938341. https://doi.org/10.1177/1043454220938341.

Full Text

Glassberg, Jeffrey A., Elizabeth A. Linton, Katrina Burson, Tabitha Hendershot, Joseph Telfair, Julie Kanter, Victor R. Gordeuk, et al. “Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry.” Orphanet J Rare Dis 15, no. 1 (July 7, 2020): 178. https://doi.org/10.1186/s13023-020-01457-x.

Full Text

Hankins, J. S., N. Shah, L. DiMartino, D. Brambilla, M. E. Fernandez, R. W. Gibson, V. R. Gordeuk, et al. “Integration of mobile health into sickle cell disease care to increase hydroxyurea utilization: Protocol for an efficacy and implementation study.” Jmir Research Protocols 9, no. 7 (July 1, 2020). https://doi.org/10.2196/16319.

Full Text

Alambo, A., R. Andrew, S. Gollarahalli, J. Vaughn, T. Banerjee, K. Thirunarayan, D. Abrams, and N. Shah. “Measuring Pain in Sickle Cell Disease using Clinical Text.” In Proceedings of the Annual International Conference of the Ieee Engineering in Medicine and Biology Society, Embs, 2020-July:5838–41, 2020. https://doi.org/10.1109/EMBC44109.2020.9175599.

Full Text

Knisely, Mitchell R., Norma Pugh, Barbara Kroner, Rita Masese, Victor Gordeuk, Allison A. King, Sharon M. Smith, et al. “Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium.” Am J Hematol, May 25, 2020. https://doi.org/10.1002/ajh.25880.

Full Text

Lopez Domowicz, Denise A., Ian Welsby, Charles R. Esther, Hongmei Zhu, Robert D. Marek, Grace Lee, Nirmish Shah, Jessica L. Poisson, and Tim J. McMahon. “Effects of repleting organic phosphates in banked erythrocytes on plasma metabolites and vasoactive mediators after red cell exchange transfusion in sickle cell disease.” Blood Transfus 18, no. 3 (May 2020): 200–207. https://doi.org/10.2450/2020.0237-19.

Full Text

Pages